Michael Gunnar Knell
CIK: 0001543779
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct1.3K shares at avg. $259.07$330K - Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct736 shares at avg. $258.53$190K - Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct1.2K shares at avg. $258.53$312K - Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct404 shares at avg. $258.53$104K - Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Exercise(M)Direct736 shares at avg. $208.44$153K - Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Exercise(M)Direct1.2K shares at avg. $194.12$234K - Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Exercise(M)Direct404 shares at avg. $179.66$73K - Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct482 shares at avg. $265.17$128K - Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct620 shares at avg. $263.94$164K - Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct213 shares at avg. $262.37$56K - Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct810 shares at avg. $261.45$212K - Aug 6, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sale(S)Direct901 shares at avg. $260.63$235K - May 31, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct48 shares at avg. $180.71$9K - May 30, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct152 shares at avg. $180.71$27K - May 29, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct1.8K shares at avg. $180.71$332K - May 27, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct37 shares at avg. $156.73$6K - May 26, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct50 shares at avg. $160.30$8K - Jan 30, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct526 shares at avg. $211.68$111K - Jan 30, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct1.7K shares- - Nov 6, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct2.9K shares at avg. $170.88$500K - Jun 1, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct225 shares at avg. $135.63$31K - May 31, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct48 shares at avg. $135.63$7K - May 30, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct2.1K shares at avg. $135.63$280K - May 28, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct25 shares at avg. $138.65$3K - May 27, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Tax Payment(F)Direct37 shares at avg. $136.73$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 1,274 | $259.07 | $330,055 | Direct |
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 736 | $258.53 | $190,278 | Direct |
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 1,205 | $258.53 | $311,529 | Direct |
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 404 | $258.53 | $104,446 | Direct |
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Exercise(M) | 736 | $208.44 | $153,412 | Direct |
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Exercise(M) | 1,205 | $194.12 | $233,915 | Direct |
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Exercise(M) | 404 | $179.66 | $72,583 | Direct |
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 482 | $265.17 | $127,812 | Direct |
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 620 | $263.94 | $163,643 | Direct |
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 213 | $262.37 | $55,885 | Direct |
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 810 | $261.45 | $211,775 | Direct |
| Aug 6, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale(S) | 901 | $260.63 | $234,828 | Direct |
| May 31, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 48 | $180.71 | $8,674 | Direct |
| May 30, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 152 | $180.71 | $27,468 | Direct |
| May 29, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 1,837 | $180.71 | $331,964 | Direct |
| May 27, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 37 | $156.73 | $5,799 | Direct |
| May 26, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 50 | $160.30 | $8,015 | Direct |
| Jan 30, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 526 | $211.68 | $111,344 | Direct |
| Jan 30, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 1,668 | - | $0 | Direct |
| Nov 6, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 2,926 | $170.88 | $499,995 | Direct |
| Jun 1, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 225 | $135.63 | $30,517 | Direct |
| May 31, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 48 | $135.63 | $6,510 | Direct |
| May 30, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 2,064 | $135.63 | $279,940 | Direct |
| May 28, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 25 | $138.65 | $3,466 | Direct |
| May 27, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Tax Payment(F) | 37 | $136.73 | $5,059 | Direct |
1-25 of 28 transactions
About Knell Michael Gunnar
Knell Michael Gunnar (SEC CIK 0001543779) files insider reports with the SEC as SVP, Finance and CAO of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
Signal8 holds 8 ownership filings by Knell Michael Gunnar, all Form 4s, filed between Feb 3, 2025 and Aug 10, 2026. Those filings report 28 transactions, from Jan 31, 2025 to Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Knell Michael Gunnar's filings is in WILMINGTON, MA.
Recent filings by Knell Michael Gunnar
- Aug 6, 2026: Open-market sales of CRL shares (4 lines, Form 4, code S).
- Aug 6, 2026: Option exercises of CRL shares (3 lines, Form 4, code M).
- Aug 6, 2026: Open-market sales of CRL shares (5 lines, Form 4, code S).
- May 31, 2026: Tax withholding of CRL shares (Form 4, code F).
- May 30, 2026: Tax withholding of CRL shares (Form 4, code F).
Other insiders filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- FOSTER JAMES C, Director
- Parisotto Shannon M, CEVP, Disc & Safety Assessment
- Coleman Glenn, EVP & Chief Financial Officer
- Girshick Birgit, Chief Executive Officer
- Andrews Nancy C, Director
- LaPlume Joseph W, EVP, Corp Strategy & Develop